Sang Hyun (Shawn) Noh

Associate

New York
shawn.noh@lw.com
+1.212.906.1736

PRACTICES

  • Capital Markets
  • Derivatives, Equities & Structured Products
  • Korea Practice

INDUSTRIES

  • Financial Institutions

BAR QUALIFICATIONS

  • New York

EDUCATION

  • JD, Harvard Law School, 2018
  • BA in Economics & Psychology, Swarthmore College, 2014
    Phi Beta Kappa

LANGUAGES SPOKEN

  • English
  • Korean

PROFILE

Shawn Noh is an associate in the New York office of Latham & Watkins.

Shawn represents issuers, funds, banks and other financial institutions in a variety of corporate and finance transactions with a focus on equity derivatives. He has experience with convertible and exchangeable note issuances and related hedging overlays, equity options, swaps, structured repurchase transactions, equity forward issuances and other hedging and monetization transactions and margin loans secured by positions in public companies.

He advises clients on a variety of transactions within the financial, real estate, pharmaceutical, entertainment, utilities, and technology industries, among others.

Shawn maintains an active pro bono practice, representing domestic abuse survivors, children, and victims of interfamilial and gender-based violence in immigration proceedings.

Prior to joining the firm full-time, Shawn was a summer associate in the New York office. He previously worked as an intern at the New York State Office of the Attorney General in the Investor Protection Bureau.

While attending law school, Shawn was an editor for the Harvard Business Law Review.

EXPERIENCE

Shawn’s representative experience includes advising:

  • Shift4 Payments on its US$690 million senior notes offering
  • K12 on its US$360 million convertible senior notes offering
  • CNX Resources Corporation on its US$342 million convertible senior notes offering
  • Coherus on its US$200 million convertible senior notes offering
  • Glaukos Corporation on its US$200 million convertible senior notes private offering
  • Nevro Corp. on its US$190 million convertible senior notes offering
  • Nevro Corp. on its US$155 million common stock offering
  • Arch Resources on its US$135 million convertible senior notes offering
  • Inspire Medical Systems on its US$130 million common stock offering
  • The underwriter in DH Europe Finance II S.A.R.L’s US$6.25 billion senior notes offering
  • The underwriter in DH Europe Finance II S.A.R.L.’s US$4 billion senior notes offering
  • The underwriter in Staples’ US$3 billion senior notes offering
  • The underwriters in Danaher’s €2.487 billion euro-denominated senior notes
  • The underwriters in Danaher’s US$1.75 billion senior notes offering
  • The underwriter in Danaher’s US$1.65 billion common stock offering
  • The underwriter in Danaher’s US$1.5 billion common stock offering
  • The underwriters in Danaher’s €750 million tack-on offering
  • The underwriter in Liberty Latin America Ltd.’s US$400 million senior notes offering
  • The initial purchasers in Peloton’s US$1 billion convertible senior notes offering
  • The initial purchasers in Middleby’s US$650 million convertible senior notes offering
  • The initial purchasers in SmileDirecClub’s US$650 million convertible senior notes offering
  • The initial purchasers in NICE’s US$400 million convertible senior notes offering
  • The initial purchaser in  SMART Global Holdings’ US$250 million senior notes offering
  • The initial purchasers in Perficient’s US$200 million convertible senior notes offering
  • The initial purchasers in Maxeon Solar Technologies’ US$185 million green convertible senior notes offering
  • The lender in IAA’s US$1.025 billion term loan and revolver
  • Lyra Therapeutics on its US$64 million IPO
  • The underwriter in TELA Bio’s US$57 million IPO